Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Read now
Xian-Yang Li, He-Zhou Guo & Jiang Zhu. (2014) Tumor suppressor activity of RIG-I. Molecular & Cellular Oncology 1:4.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:2.
Read now
Read now
Articles from other publishers (14)
Madhu Gupta, Abhishek Wahi, Priyanka Sharma, Riya Nagpal, Neha Raina, Monika Kaurav, Jaydeep Bhattacharya, Sonia M. Rodrigues Oliveira, Karma G. Dolma, Alok K. Paul, Maria de Lourdes Pereira, Polrat Wilairatana, Mohammed Rahmatullah & Veeranoot Nissapatorn. (2022) Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines 10:12, pages 2011.
Crossref
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Kiavash Hushmandi, Masoud Delfi, Haroon Khan, Milad Ashrafizadeh, Gautam Sethi & Alan Prem Kumar. (2021) Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy. Cells 10:12, pages 3348.
Crossref
Crossref
Sandra Iurescia, Daniela Fioretti & Monica Rinaldi. (2020) The Innate Immune Signalling Pathways: Turning RIG-I Sensor Activation against Cancer. Cancers 12:11, pages 3158.
Crossref
Crossref
Faizan Ahmad. (2020) Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies. Biomedical and Biotechnology Research Journal (BBRJ) 4:3, pages 179.
Crossref
Crossref
Mike W. Helms, Kerstin Jahn-Hofmann, Felix Gnerlich, Christiane Metz-Weidmann, Monika Braun, Gabriele Dietert, Petra Scherer, Kaj Grandien, Joachim Theilhaber, Hui Cao, Timothy R. Wagenaar, Max M. Schnurr, Stefan Endres, Dmitri Wiederschain, Sabine Scheidler, Simon Rothenfußer, Bodo Brunner & Lars M. König. (2019) Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy. Molecular Cancer Therapeutics 18:12, pages 2343-2356.
Crossref
Crossref
Sandra Iurescia, Daniela Fioretti & Monica Rinaldi. (2018) Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies. Frontiers in Immunology 9.
Crossref
Crossref
Ruth Seelige, Stephen Searles & Jack D. Bui. (2017) Mechanisms regulating immune surveillance of cellular stress in cancer. Cellular and Molecular Life Sciences 75:2, pages 225-240.
Crossref
Crossref
Yuanbing Wu, Xinqiang Wu, Longhuo Wu, Xiangcai Wang & Zhiping Liu. (2017) The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy. Translational Research 190, pages 51-60.
Crossref
Crossref
Huey-Jen Lin & Jiayuh Lin. (2017) Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment. Cancers 9:12, pages 93.
Crossref
Crossref
G. Hartmann. 2017.
121
169
.
Adele Alagia & Ramon Eritja. (2016)
siRNA
and
RNAi
optimization
. WIREs RNA 7:3, pages 316-329.
Crossref
Crossref
Laurence Zitvogel, Lorenzo Galluzzi, Oliver Kepp, Mark J. Smyth & Guido Kroemer. (2015) Type I interferons in anticancer immunity. Nature Reviews Immunology 15:7, pages 405-414.
Crossref
Crossref
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Crossref
Jing Zhang, Xiang Li & Leaf Huang. (2014) Non-viral nanocarriers for siRNA delivery in breast cancer. Journal of Controlled Release 190, pages 440-450.
Crossref
Crossref